These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6198273)

  • 1. HLA-DR7-specific monoclonal antibodies and a chimpanzee anti-DR7 serum detect different epitopes on the same molecule.
    Radka SF; Amos DB; Quackenbush LJ; Cresswell P
    Immunogenetics; 1984; 19(1):63-76. PubMed ID: 6198273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines.
    Horibe K; Flomenberg N; Pollack MS; Adams TE; Dupont B; Knowles RW
    J Immunol; 1984 Dec; 133(6):3195-202. PubMed ID: 6208273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cross-reactive T cell restriction epitopes located on the DR7 beta 1 and DR beta 4 molecules.
    Bismuth G; Gouy H; Karr RW; Debré P
    Hum Immunol; 1990 Jul; 28(3):271-83. PubMed ID: 1695622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of HLA-DQ molecules with a monoclonal antibody detecting a DQ polymorphism absent from DQW1 homozygous cells.
    Radka SF; Stewart SJ; Smith SA
    Hum Immunol; 1985 Nov; 14(3):206-19. PubMed ID: 3863810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules.
    Horibe K; Knowles RW; Dupont B
    Hum Immunol; 1986 May; 16(1):14-23. PubMed ID: 2423484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative expression of epitopes defined by murine monoclonal antibodies on DR molecules from different HLA haplotypes.
    Letarte M; Addis J; Iturbe S; Petsche D
    Biosci Rep; 1985; 5(10-11):923-31. PubMed ID: 2420387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of monoclonal antibodies reactive with human class II beta chains by two-dimensional electrophoresis and Western blotting.
    Radka SF; Machamer CE; Cresswell P
    Hum Immunol; 1984 Jul; 10(3):177-86. PubMed ID: 6611328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of three class II antigens, DR7, MB2, and MT3, from a homozygous human cell line.
    Shackelford DA; Strominger JL
    Hum Immunol; 1984 Mar; 9(3):159-74. PubMed ID: 6199337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
    Matsuyama T; Schwenzer J; Silver J; Winchester R
    J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple regions of HLA-DR beta 1 chains determine polymorphic epitopes recognized by monoclonal antibodies.
    Alber CA; Watts R; Klohe EP; Drover S; Marshall WH; Radka SF; Karr RW
    J Immunol; 1989 Oct; 143(7):2248-55. PubMed ID: 2476501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence and evolution of HLA-DR7- and -DRw53-associated beta-chain genes.
    Young JA; Wilkinson D; Bodmer WF; Trowsdale J
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4929-33. PubMed ID: 3110774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE).
    Granados J; Vargas-Alarcón G; Drenkard C; Andrade F; Melín-Aldana H; Alcocer-Varela J; Alarcón-Segovia D
    Lupus; 1997; 6(1):57-62. PubMed ID: 9116720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A matrix approach to human class II histocompatibility antigens: reactions of four monoclonal antibodies with the products of nine haplotypes.
    Brodsky FM
    Immunogenetics; 1984; 19(3):179-94. PubMed ID: 6200433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SFR3-DR5, a monoclonal antibody with HLA-DR5 specificity.
    Radka SF; Machamer C; Cresswell P; Kostyu DD; Ward FE; Amos DB
    J Immunol; 1983 Apr; 130(4):1863-6. PubMed ID: 6187822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Ia molecules carrying MT1 determinants: purification with a monoclonal antibody.
    Falk JA; Lewis WH; Letarte M
    Hum Immunol; 1985 Aug; 13(4):265-80. PubMed ID: 2411699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the immune response in multiple sclerosis: production of monoclonal antibodies specific to HLA/myelin basic protein.
    Puri J; Arnon R; Gurevich E; Teitelbaum D
    J Immunol; 1997 Mar; 158(5):2471-6. PubMed ID: 9036999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility complex class II-restricted antigen presentation across a species barrier: conservation of restriction determinants in evolution.
    Bontrop RE; Elferink DG; Otting N; Jonker M; de Vries RR
    J Exp Med; 1990 Jul; 172(1):53-9. PubMed ID: 1694228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New polymorphic HLA-DR epitopes recognized by three monoclonal antibodies produced against DR103 transfected L cells.
    Cayrol C; Moro F; Sommer E; Tkaczuk J; Ohayon E; Cambon-Thomsen A
    Tissue Antigens; 1992 Oct; 40(4):197-203. PubMed ID: 1281933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of HLA-DRB and -DQB gene RFLPs in DR7 homozygous cell lines: associations with Dw11, Dw17 and DB1.
    Carlsson B; Wallin J
    Tissue Antigens; 1991 Feb; 37(2):74-8. PubMed ID: 1676192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.